Jerome Jabbour | Chief Executive Officer |
Theresa Matkovits | Chief Development Officer |
Terry Ferguson | Chief Medical Officer |
Keith Kucinski | Chief Financial Officer |
Peter Vozzo | Investor Relations |
Bert Hazlett | BTIG |
Welcome to the Matinas BioPharma first quarter 2022 results conference call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation.
As a reminder, this conference is being recorded. I would now like to turn the conference over to Peter Vozzo, Investor Relations representative for Matinas BioPharma.